Alps Advisors Inc Sarepta Therapeutics, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$97.32 - $148.76 $151,235 - $231,173	-1,554 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$115.31 - $161.51 $72,184 - $101,105	-626 Reduced 28.72%	1,554 $251,000
Q2 2018 Aug 02, 2018	SELL	$71.74 - $153.69 $4.98 Million - $10.7 Million	-69,439 Reduced 96.96%	2,180 $288,000
Q2 2018 Jul 25, 2018	SELL	$71.74 - $153.69 $1.08 Million - $2.32 Million	-15,066 Reduced 17.38%	71,619 $3.99 Million
Q1 2018 May 01, 2018	BUY	$54.02 - $82.27 $813,865 - $1.24 Million	15,066 Added 21.04%	86,685 $6.42 Million
Q4 2017 Feb 05, 2018	BUY	$47.64 - $56.75 $3.41 Million - $4.06 Million	71,619	71,619 $3.99 Million

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.